Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2111358 Target Snapshot

Prostaglandin G/H synthase (cyclooxygenase) · PROTEIN FAMILY · Ovis aries

124Compounds
16Assays
1Approved Drugs
42.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P05979. Use UniProt P05979 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P05979 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Prostaglandin G/H synthase (cyclooxygenase) as ChEMBL target CHEMBL2111358, mapped to UniProt P05979. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Prostaglandin G/H synthase (cyclooxygenase)
PROTEIN FAMILY · Ovis aries
As of 2026-09-14
ChEMBL target ID
CHEMBL2111358
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P05979
Prostaglandin G/H synthase 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Prostaglandin G/H synthase (cyclooxygenase) is the right protein anchor across sources, using UniProt P05979 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProstaglandin G/H synthase 1
UniProt AccessionP05979
Component TypeProtein
Sequence Length600 aa

Prostaglandin G/H synthase 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Prostaglandin G/H synthase (cyclooxygenase), mapped to UniProt P05979. ChEMBL maps the protein component as Prostaglandin G/H synthase 1. Sequence length is 600 aa.

Mapped IDP05979
Review nameProstaglandin G/H synthase (cyclooxygenase)
OrganismOvis aries
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5042.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL284705 7.0 IC50 100.0 Preclinical
CHEMBL33378 7.0 IC50 100.0 Preclinical
CHEMBL6 6.82 IC50 150.0 Approved
CHEMBL33987 6.52 IC50 300.0 Preclinical
CHEMBL274642 5.89 IC50 1300.0 Preclinical
CHEMBL34003 5.89 IC50 1300.0 Preclinical
CHEMBL285188 5.85 IC50 1400.0 Preclinical
CHEMBL32961 5.85 IC50 1400.0 Preclinical
CHEMBL32990 5.75 IC50 1800.0 Preclinical
CHEMBL286802 5.16 IC50 7000.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
5
5.5
0
6.0
3
6.5
2
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

INDOMETHACIN
CHEMBL6
Approved 1965
Assay Landscape

Assay Landscape

16
Total Assays
19
Tested Compounds
2
Assay Types
Binding — 15 assays, 19 compounds
BAO Format Assays Compounds Avg pChEMBL
protein format 9 0
tissue-based format 6 19 5.5
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine